Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance

Stratton, Charles W.

Back to Previous Page

Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance

Published Date:

Jan 2003

Source:

Emerg Infect Dis. 9(1):10-16.

[PDF-221.16 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Stratton, Charles W.

Description:

The global emergence of antibacterial resistance among common and atypical respiratory pathogens in the last decade necessitates the strategic application of antibacterial agents. The use of bactericidal rather than bacteriostatic agents as first-line therapy is recommended because the eradication of microorganisms serves to curtail, although not avoid, the development of bacterial resistance. Bactericidal activity is achieved with specific classes of antimicrobial agents as well as by combination therapy. Newer classes of antibacterial agents, such as the fluoroquinolones and certain members of the macrolide/lincosamine/streptogramin class have increased bactericidal activity compared with traditional agents. More recently, the ketolides (novel, semisynthetic, erythromycin-A derivatives) have demonstrated potent bactericidal activity against key respiratory pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, Chlamydia pneumoniae, and Moraxella catarrhalis. Moreover, the ketolides are associated with a low potential for inducing resistance, making them promising first-line agents for respiratory tract infections.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

File Type:

Supporting Files:

	02-0172.nxml	text/plain
	license.txt	text/plain

No Related Documents.

Hidden Epidemic of Macrolide-resistant Pneumococci

[PDF - 208.63 KB]

Personal Author:

Klugman, Keith P. ; Lonks, John R. ;

Published Date:

Jun 2005

Source:

Emerg Infect Dis. 11(6):802-807.

Description:

Community-acquired respiratory tract infections (RTIs) account for a substantial proportion of outpatient antimicrobial drug prescriptions worldwide. ...

File Type:

[PDF - 208.63 KB]

File Type:

[PDF - 208.63 KB]
Connecticut inhalation anthrax case confirmed

[PDF - 593.95 KB]

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

11/21/2001

Series:

HAN ; 058

Description:

Wednesday, November 21, 2001, 21:05 EST (9:05 PM EST)CDCHAN-00058-2001-11-21-UPD-NCDC has confirmed a case of inhalational anthrax in Connecticut. Yes...

File Type:

[PDF - 593.95 KB]

File Type:

[PDF - 593.95 KB]
Aeromonas spp. and Traveler’s Diarrhea: Clinical Features and Antimicrobial Resistance

[PDF - 248.98 KB]

Personal Author:

Vila, Jordi ; Ruiz, Joaquin ; ...

Published Date:

May 2003

Source:

Emerg Infect Dis. 9(5):552-555.

Description:

Traveler's diarrhea is the most common health problem of international travelers. We determined the prevalence of Aeromonas spp. associated with trave...

File Type:

[PDF - 248.98 KB]

File Type:

[PDF - 248.98 KB]
16S rRNA Methylase–producing, Gram-Negative Pathogens, Japan

[PDF - 236.19 KB]

Personal Author:

Yamane, Kunikazu ; Wachino, Jun-ichi ; ...

Published Date:

Apr 2007

Source:

Emerg Infect Dis. 13(4):642-646.

Description:

To investigate the exact isolation frequency of 16S rRNA methylase-producing, gram-negative pathogenic bacteria, we tested 87,626 clinical isolates fr...

File Type:

[PDF - 236.19 KB]

File Type:

[PDF - 236.19 KB]
Snort. Sniffle. Sneeze. No antibiotics please

[PDF - 363.66 KB]

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

2/12/09

Series:

Get Smart : know when antibiotics work

Description:

Treat colds and flu with care. Talk to your healthcare provider.As a parent, you want to help your child feel better. But antibiotics aren’t always ...

File Type:

[PDF - 363.66 KB]

File Type:

[PDF - 363.66 KB]

Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance

Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC